Treatment for melanoma
US9572828B2 · kind B2 · utility
0Cited by
2References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2014 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Jul 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include MEK inhibitors combination with cardiac glycosides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.